DSI, pharmaceutical association to collaborate on healthcare R&D
The Department of Science and Innovation (DSI), the South African Medical Research Council (SAMRC) and the Innovative Pharmaceutical Association of South Africa (IPASA) this week signed a memorandum of understanding (MoU) to advance South Africa's objectives to research, develop and, ultimately, commercialise innovative health solutions.
The MoU provides for the parties to cooperate and collaborate through establishing research programmes focusing on communicable and non-communicable diseases – from discovery through preclinical and clinical development.
The MoU is also aimed at building on the resource and infrastructure investment of both the South African government and members of IPASA, creating partnerships that focus on capacity building skills and development across the pharmaceutical value chain to strengthen the research and development (R&D) ecosystem in South Africa; building on leveraging the existing strengths related to precision medicine to improve access to improved precision medicines to South Africa’s diverse population; and creating partnerships to boost pharmaceutical manufacturing in the country.
IPASA, as a voluntary association comprising innovative multinational pharmaceutical companies including Merck, Pfizer, Novartis, Roche, Sanofi, GSK, AstraZeneca and others, is committed to advancing R&D activities in South Africa and on the continent, which is aligned to both DSI's and SAMRC’s mandates.
“By working together, we want to deliver innovative and affordable solutions for infectious and non-communicable diseases for our country. This collaboration will build on the already existing successful partnership between the SAMRC and the DSI and will facilitate the development and implementation of a comprehensive programme of interventions across the pharmaceutical development pipeline,” said SAMRC president Professor Glenda Gray.
Comments
Press Office
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation